L. S. Clark

Identification and chromosomal assignment of two heterozygous mutations in the Trp53 gene in L5178Y/Tk(+/-)-3.7.2C mouse lymphoma cells.

J. Barrett, L. S. Clark, D. W. Hart, 1998, Mutagenesis.

Activators of spleen glucocerebrosidase from controls and patients with various forms of Gaucher's disease.

L. S. Clark, R. Glew, A. Basu, 1984, The Journal of biological chemistry.

Further studies on the activation of glucocerebrosidase by a heat-stable factor from Gaucher spleen.

L. S. Clark, R. Glew, A. Basu, 1985, Archives of biochemistry and biophysics.

Loss of P53 heterozygosity is not responsible for the small colony thymidine kinase mutant phenotype in L5178Y mouse lymphoma cells.

L. S. Clark, M. Moore, L. Sargent, 2004, Mutagenesis.

ARTEMIA HEMOGLOBINS: GENETIC VARIATION IN PARTHENOGENETIC AND ZYGOGENETIC POPULATIONS

L. S. Clark, S. Bowen, James P. Durkin, 1978 .

The genetics of Artemia salina. VII. Reproductive isolation.

L. S. Clark, S. Bowen, S. T. Bowen, 1976, The Journal of heredity.

Enzymic Differentiation of Neurologic and Nonneurologic Forms of Gaucher's Disease

L. S. Clark, R. Glew, L. B. Daniels, 1982, Journal of Neuropathology and Experimental Neurology.

The aminothiol WR-1065 protects T lymphocytes from ionizing radiation-induced deletions of the HPRT gene.

R. Albertini, J. Nicklas, L. S. Clark, 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Genetic heterogeneity beyond CYP2C8*3 does not explain differential sensitivity to paclitaxel-induced neuropathy

L. Carey, H. McLeod, A. Motsinger-Reif, 2014, Breast Cancer Research and Treatment.

Radiation quality affects the efficiency of induction and the molecular spectrum of HPRT mutations in human T cells.

R. Albertini, J. Nicklas, J. O’Neill, 1997, Radiation research.

CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel.

L. Carey, H. McLeod, A. Motsinger-Reif, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Prospective CYP2D6 genotyping as an exclusion criterion for enrollment of a phase III clinical trial.

J. Polli, M. Cayouette, L. S. Clark, 2000, Pharmacogenetics.

The effect of streptomycin on oxygen uptake and viability of resting suspensions of Escherichia coli.

L. S. Clark, T. F. Paine, 1953, Science.

Hprt mutations in human T-lymphocytes reflect radioprotective effects of the aminothiol, WR-1065.

R. Albertini, J. Nicklas, L. S. Clark, 1996, Carcinogenesis.

CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel.

L. Carey, H. McLeod, A. Motsinger-Reif, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.